Description |
1 online resource (163 pages) : color illustrations |
Series |
Clinical Insights, 2047-332X |
|
Clinical insights (London, England)
|
Contents |
Antiangiogenesis in cancer therapy -- Mechanism of action of approved antiangiogenesis agents: overview for clinicians -- Imaging angiogenesis: role in measuring response to treatment -- Focus on renal cancer -- Antiangiogenesis: focus on colorectal cancer -- Angiogenesis inhibitors and vascular disrupting agents for non-small-cell lung cancer -- Antiangiogenesis in cancer therapy: focus on ovarian cancer -- Angiogenesis inhibitors in brain cancer treatment -- Learning from failures and successes, and identifying patients that may benefit from antiÂƯangiogenesis therapy |
Summary |
This book presents a succinct guide to angiogenesis inhibitors in clinical development and the evidence for angiogenesis inhibition across a broad range of tumors. It presents updates from the clinical research field and opinions on how antiangiogenic strategies may be optimized for therapeutic benefit |
Bibliography |
Includes bibliographical references and index |
Notes |
Online resource; title from cover art from information screen (viewed February 3, 2023) |
Subject |
Cancer -- Treatment.
|
|
Neovascularization inhibitors.
|
|
Angiogenesis Inhibitors
|
|
Neoplasms -- therapy
|
|
Neovascularization inhibitors
|
|
Cancer -- Treatment
|
Form |
Electronic book
|
Author |
Basu, Bristi, editor.
|
|
Biswas, Swethajit, editor.
|
|
Pacey, Simon, editor.
|
ISBN |
9781780843766 |
|
1780843763 |
|
9781780843759 |
|
1780843755 |
|